---
title: "C&Y Pharmaceutical issued a preliminary profit increase announcement, expecting an annual net profit of 40 million to 52 million yuan, a year-on-year increase of 58.76%-106.39%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/226160703.md"
description: "According to the Zhitong Finance APP, C&Y Pharmaceutical disclosed its performance forecast for 2024, expecting a net profit attributable to shareholders of the listed company to be between 40 million and 52 million yuan, a year-on-year increase of 58.76%-106.39%; the net profit after deducting non-recurring gains and losses is expected to be between 22 million and 34 million yuan"
datetime: "2025-01-24T12:43:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/226160703.md)
  - [en](https://longbridge.com/en/news/226160703.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/226160703.md)
generator: "portal-rs"
---

# C&Y Pharmaceutical issued a preliminary profit increase announcement, expecting an annual net profit of 40 million to 52 million yuan, a year-on-year increase of 58.76%-106.39%

According to the Zhitong Finance APP, C&Y Pharmaceutical (300254.SZ) disclosed its performance forecast for 2024, expecting a net profit attributable to shareholders of the listed company to be between 40 million and 52 million yuan, a year-on-year increase of 58.76%-106.39%; the net profit after deducting non-recurring gains and losses is expected to be between 22 million and 34 million yuan

### Related Stocks

- [300254.CN](https://longbridge.com/en/quote/300254.CN.md)

## Related News & Research

- [Trump announces Medicaid drug pricing deals with 9 firms](https://longbridge.com/en/news/297557074.md)
- [18:06 ETUltra Violette Becomes First Brand in the US to Launch a Sunscreen Containing Newly FDA-Approved Filter Bemotrizinol](https://longbridge.com/en/news/297566389.md)
- [Logintrade Subsidiary Zingflow Rebrands as Select8](https://longbridge.com/en/news/297533009.md)
- [Livzon MABPharm wins China approval for Lecankitug psoriasis injection](https://longbridge.com/en/news/297167246.md)
- [AusperBio raises $120m to progress hepatitis B therapies](https://longbridge.com/en/news/297479238.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**